Ordering Recommendation

Adjunct test for the investigation of hyperandrogenic and adrenal disorders. Not recommended for initial evaluation of polycystic ovarian syndrome.

Mnemonic

DHEA TMS

Methodology

Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry

Performed

Sun-Sat

Reported

1-4 days

New York DOH Approval Status

This test is New York DOH approved.

Specimen Required

Patient Preparation

Collect between 6-10 a.m.

Collect

Serum separator tube or green (sodium or lithium heparin). Also acceptable: Lavender (EDTA).

Specimen Preparation

Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions
Remarks
Stability

After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 6 months

Reference Interval

Effective August 19, 2013

Age Female Male
Premature Less than 40 ng/mL Less than 40 ng/mL
0-1 day Less than 11 ng/mL Less than 11 ng/mL
2-6 days Less than 8.7 ng/mL Less than 8.7 ng/mL
7 days-1 month Less than 5.8 ng/mL Less than 5.8 ng/mL
1-5 months Less than 2.9 ng/mL Less than 2.9 ng/mL
6-24 months Less than 1.9 9 ng/mL Less than 2.5 ng/mL
2-3 years Less than 0.85 ng/mL Less than 0.63 ng/mL
4-5 years Less than 1.03 ng/mL Less than 0.95 ng/mL
6-7 years Less than 1.79 ng/mL 0.06-1.93 ng/mL
8-9 years 0.14-2.35 ng/mL 0.10-2.08 ng/mL
10-11 years 0.43-3.78 ng/mL 0.32-3.08 ng/mL
12-13 years 0.89-6.21 ng/mL 0.57-4.10 ng/mL
14-15 years 1.22-7.01 ng/mL 0.93-6.04 ng/mL
16-17 years 1.42-9.00 ng/mL 1.17-6.52 ng/mL
18-39 years 1.33-7.78 ng/mL 1.33-7.78 ng/mL
40 years and older 0.63-4.70 ng/mL 0.63-4.70 ng/mL
Postmenopausal 0.60-5.73 ng/mL Does Not Apply
Tanner Stage I 0.14-2.76 ng/mL 0.11-2.37 ng/mL
Tanner Stage II 0.83-4.87 ng/mL 0.37-3.66 ng/mL
Tanner Stage III 1.08-7.56 ng/mL 0.75-5.24 ng/mL
Tanner Stage IV-V 1.24-7.88 ng/mL 1.22-6.73 ng/mL

Interpretive Data

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

82626

Components

Component Test Code* Component Chart Name LOINC
2001641 Dehydroepiandrosterone by TMS 2193-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • DHEA (Dehydroepiandrosterone, Serum or Plasma)
  • Unconjugated DHEA (Dehydroepiandrosterone, Serum or Plasma)
Dehydroepiandrosterone, Serum or Plasma